WINNINGHAM RICK E (Chief Executive Officer) received a stock award from THERAVANCE BIOPHARMA, INC.
Compensation award — not an open‑market transaction. Less informative as a directional signal.
A · 1 award
Filed: 4/3/2026ACC: 0001302443-26-000004
DirectorOfficer· Chief Executive Officer
Since Aug 2018
+75K
Net shares
Net buyer
$0.00
Total acquired
0
Open market trades
0B · 0S
1
Total transactions
75K acquired
Non-Derivative Transactions1
Ordinary Shares
Direct
Shares
+75K
Price / share
—
Trade value
—
% of position
4.8%
4/1/2026
1.58M→1.65M
Total
Net shares
+75K
Net value
$0.00
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Ordinary Shares Direct | 4/1/2026 | A · Award | +75K | — | — | 4.8% | 1.58M | 1.65M |
| Total | +75K | $0.00 | ||||||
Derivative Transactions0
No derivative transactions reported
Non-Derivative Holdings (Post-Transaction)2
Ordinary Shares
IndirectShares owned23.40K
Ordinary Shares
IndirectShares owned92.57K
Total
115.97K indirect115.97K
| Security Title | Shares Owned | Ownership Type |
|---|---|---|
| Ordinary Shares | 23.40K | Indirect |
| Ordinary Shares | 92.57K | Indirect |
| Total | 115.97K | 115.97K indirect |
Derivative Holdings (Post-Transaction)0
No derivative holdings reported